Effect of Aspirin on Incidence, Recurrence, and Mortality in Prostate Cancer Patients: Integrating Evidence From Randomized Controlled Trials and Real-World Studies
Document Type
Article
Publication Title
European Journal of Clinical Pharmacology
Abstract
Purpose: Aspirin has been suggested to reduce the risk of cancer. However, previous studies have been inconsistent regarding the relationship between aspirin use and the risk of occurrence of prostate cancer (PCa). The purpose of this study was to assess the effect of aspirin on clinical outcomes in patients with PCa in a meta-analysis and to explore the possible dose-response relationship.
Methods: A systematic literature search was conducted in 10 electronic databases and 4 registries. The combined relative risks (RRs) were calculated using a random-effects model with 95% confidence interval (CIs) to assess the effect of aspirin on the risk of PCa. Relevant subgroup analyses and sensitivity analyses were performed.
Results: The across studies results show that aspirin use associated with lower incidence of PCa (RR: 0.96, 95% CI: 0.95-0.98), and reduced mortality (RR: 0.88, 95% CI: 0.82-0.95). The results of the subgroup analysis indicated that both cohort and population studies in the Americas showed a reduction in PCa incidence and mortality with aspirin use. A linear correlation was observed between dosage/duration of aspirin use and its protective effect. Additionally, post-diagnosis aspirin use was associated with decreased risk of PCa mortality.
Conclusions: This meta-analysis revealed an independent correlation between the use of aspirin and reductions in both the incidence and mortality rates of PCa. However, randomized controlled trials did not find any association between aspirin use and PCa. Furthermore, the impact of aspirin on PCa occurrence was found to be dependent on both dosage and duration.
DOI
10.1007/s00228-023-03556-7
Publication Date
8-30-2023
Keywords
Aspirin, Dose-response relationship, Meta-analysis, Prostate cancer
ISSN
1432-1041
Recommended Citation
Ma S, Xia W, Wu B, Sun C, Jiang Y, Liu H, Lowe S, Zhou Z, Xie P, Gao J, Feng L, Guo X, Qu G, Sun Y. Effect of Aspirin on Incidence, Recurrence, and Mortality in Prostate Cancer Patients: Integrating Evidence From Randomized Controlled Trials and Real-World Studies. European Journal of Clinical Pharmacology. 2023; . doi: 10.1007/s00228-023-03556-7.
